Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma
about
Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma
description
clinical trial
@en
ensayo clínico
@es
klinisch onderzoek
@nl
name
Comparison of MAPI+Camrelizuma ...... gnosed High-grade Osteosarcoma
@en
type
label
Comparison of MAPI+Camrelizuma ...... gnosed High-grade Osteosarcoma
@en
prefLabel
Comparison of MAPI+Camrelizuma ...... gnosed High-grade Osteosarcoma
@en
P921
P1050
P1476
A Randomized Trial of Comparis ...... Open-label, Exploratory Study
@en
P1813
MAPAC
@en
P3098
NCT04351308
P4844
P580
2020-05-01T00:00:00Z
P582
2022-09-01T00:00:00Z